Role of virechana karma in metabolic syndrome- Clinical trial
Priyanka Sharma, Alok Srivastava, Shashi Kant Tiwari and 1 more
Environment Conservation Journal · 2019
doi:10.36953/ecjse.2019.02005 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Metabolic Syndrome is a constellation of several factors like hyperglycemia, raised blood pressure, insulin resistance, dyslipidemia, and central obesity. Among these factors central obesity & insulin resistance are the dominant parameters of this collection. In today’s era its prevalence is rising rapidly and it has a high socioeconomic burden. Being the major risk factor for Cardio Vascular Disease and Type 2 Diabetes Mellitus, it is the need of the hour to find a safe and cost effective remedy for Metabolic Syndrome. Santarpana Nimittaj Vikara in Ayurvedic Classics can be correlated to Metabolic Syndrome and Virechana Karma is an effective measure which helps in cleansing congested Strotas and removing vitiated Dosha hence pacifying the symptoms of Metabolic Syndrome. Patients of either sex in the age group of 20 to 60 years, fulfilling the study criteria were included in the study. Two sittings of Virechana Karma were administered with 15 day gap in between. Highly significant in all criteria except Blood sugar fasting. Conclusion: Virechana Karma is an ideal therapy for Metabolic Syndrome
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.